Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Cited In for PubMed (Select 21254289)

2.

Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.

Kimura G, Kadoyama K, Brown JB, Nakamura T, Miki I, Nisiguchi K, Sakaeda T, Okuno Y.

Int J Med Sci. 2015 Jan 5;12(2):135-40. doi: 10.7150/ijms.10453. eCollection 2015.

4.

Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.

Jackson JW, Schneeweiss S, VanderWeele TJ, Blacker D.

PLoS One. 2014 Aug 20;9(8):e105376. doi: 10.1371/journal.pone.0105376. eCollection 2014.

5.

Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish.

Bruni G, Lakhani P, Kokel D.

Front Pharmacol. 2014 Jul 24;5:153. doi: 10.3389/fphar.2014.00153. eCollection 2014. Review.

6.

Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.

Galbally M, Snellen M, Power J.

Ther Adv Drug Saf. 2014 Apr;5(2):100-9. doi: 10.1177/2042098614522682. Review.

7.

Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.

Hanley GE, Mintzes B.

BMC Pregnancy Childbirth. 2014 Jul 22;14:242. doi: 10.1186/1471-2393-14-242.

9.

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.

Godman B, Petzold M, Bennett K, Bennie M, Bucsics A, Finlayson AE, Martin A, Persson M, Piessnegger J, Raschi E, Simoens S, Zara C, Barbui C.

BMC Med. 2014 Jun 13;12:98. doi: 10.1186/1741-7015-12-98.

10.

A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies.

Kulkarni J, Worsley R, Gilbert H, Gavrilidis E, Van Rheenen TE, Wang W, McCauley K, Fitzgerald P.

PLoS One. 2014 May 2;9(5):e94788. doi: 10.1371/journal.pone.0094788. eCollection 2014.

11.

Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Bachmann CJ, Lempp T, Glaeske G, Hoffmann F.

Dtsch Arztebl Int. 2014 Jan 17;111(3):25-34. doi: 10.3238/arztebl.2014.0025.

12.

Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.

Remington G, Hahn M.

J Psychiatry Neurosci. 2014 Jan;39(1):E1-2. doi: 10.1503/jpn.120205. No abstract available.

13.

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.

Raschi E, Poluzzi E, Godman B, Koci A, Moretti U, Kalaba M, Bennie M, Barbui C, Wettermark B, Sturkenboom M, De Ponti F.

PLoS One. 2013 Nov 20;8(11):e81208. doi: 10.1371/journal.pone.0081208. eCollection 2013.

14.

Use of antipsychotic medications in pediatric populations: what do the data say?

Penfold RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR, Owen-Smith AA, Rossom RC, Lu CY, Lynch FL, Waitzfelder BE, Coleman KJ, Ahmedani BK, Beck AL, Zeber JE, Simon GE.

Curr Psychiatry Rep. 2013 Dec;15(12):426. doi: 10.1007/s11920-013-0426-8. Review. Erratum in: Curr Psychiatry Rep. 2014 Feb;16(2):432. Coleman, Karen A [corrected to Coleman, Karen J].

15.

Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications.

Birnbaum ML, Saito E, Gerhard T, Winterstein A, Olfson M, Kane JM, Correll CU.

Curr Psychiatry Rep. 2013 Aug;15(8):382. doi: 10.1007/s11920-013-0382-3. Review.

16.

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.

Sadowski A, Todorow M, Yazdani Brojeni P, Koren G, Nulman I.

BMJ Open. 2013 Jul 13;3(7). pii: e003062. doi: 10.1136/bmjopen-2013-003062. Print 2013.

17.

The use of clinical trials in comparative effectiveness research on mental health.

Blanco C, Rafful C, Olfson M.

J Clin Epidemiol. 2013 Aug;66(8 Suppl):S29-36. doi: 10.1016/j.jclinepi.2013.02.013.

18.

Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011.

Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH.

Schizophr Res. 2013 Aug;148(1-3):99-104. doi: 10.1016/j.schres.2013.05.019. Epub 2013 Jun 17.

19.

Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs.

Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg A, Dow WH, Hui R, Frank R, Newhouse JP, Hsu J.

Med Care. 2013 Jul;51(7):614-21. doi: 10.1097/MLR.0b013e31829019c5.

20.

Diffusion of antipsychotics in the US And French markets, 1998-2008.

Gallini A, Donohue JM, Huskamp HA.

Psychiatr Serv. 2013 Jul 1;64(7):680-7. doi: 10.1176/appi.ps.004662012.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk